In-vivo experiments using selegiline displacement in patients with Alzheimer’s disease and PSP indicate that [18F]-THK5351 may bind to MAO-B [40], suggesting that [18F]-THK5351 binds to astrogliosis. Here, MAOB is linked to early-onset autosomal dominant Alzheimer disease.